Related Links
Recent Publications
Biomarkerless targeting and photothermal cancer cell killing by surface-electrically-charged superparamagnetic Fe3O4 composite nanoparticles. Han X, Deng Z, Yang Z, Wang Y, Zhu H, Chen B, Cui Z, Ewing RC, Shi D.. Nanoscale. 2017;9(4):1457-1465.
Granulocytes as an effector mechanism of BCG therapy for bladder cancer. Davis RL III, Le W, Cui Z.. Med Hypotheses. 2017;104():166-169.
Facile synthesis of Gd-functionalized gold nanoclusters as potential MRI/CT contrast agents. Le WJ, Cui SB, Chen X, Zhu HH, Chen BD, Cui Z.. Nanomaterials. 2016;6(4):65.
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody. Liu F, Le W, Mei T, Wang T, Chen L, Lei Y, Cui S, Chen B, Cui Z, Shao C.. Int J Nanomedicine. 2016;19(11):2195-2207.
Targeting negative surface charges of cancer cells by multifunctional nanoprobes. Chen B, Le W, Wang Y, Li Z, Wang D, Ren L, Lin L, Cui S, Hu JJ, Hu Y, Yang P, Ewing RC, Shi D, Cui Z.. Theranostics. 2016;6(11):1887-1898.
Novel innate cancer killing activity in humans. Blanks MJ, Stehle JR Jr, Du W, Adams JM, Willingham MC, Allen GO, Hu JJ, Lovato J, Molnar I, Cui Z.. Cancer Cell Int. 2011;11():article 26.
Cancer resistance of SR/CR mice in the genetic knockout backgrounds of leukocyte effector mechanisms: determinations for functional requirements. Sanders AM, Stehle JR Jr, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Monjazeb AM, Adams JM, Willingham MC, Cui Z.. BMC Cancer. 2010;10():art. 121.
The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction. Riedlinger G, Adams J, Stehle JR Jr, Blanks MJ, Sanders AM, Hicks AM, Willingham MC, Cui Z.. BMC Cancer. 2010;10():179.
Phospholipid profiling by tandem mass spectrometry. Cui Z, Thomas MJ.. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877(26):2709-2715.
Impact of sex, MHC, and age of recipients on the therapeutic effect of transferred leukocytes from cancer-resistant SR/CR mice. Stehle JR Jr, Blanks MJ, Riedlinger G, Kim-Shapiro JW, Sanders AM, Adams JM, Willingham MC, Cui Z.. BMC Cancer. 2009;9():art. 328.
In situ immunocytochemical detection of altered membrane composition induced by cell-cell contact in cultured mammalian cells. Du W, Cui Z, Tsui ZC, Chen Q, Willingham MC.. Microsc Res Tech. 2008;71(10):749-759.
Mass spectrometry identification of circulating alpha-1-B glycoprotein, increased in aged female C57BL/6 mice. Stehle JR Jr, Weeks ME, Lin K, Willingham MC, Hicks AM, Timms JF, Cui Z.. Biochim Biophys Acta. 2007;1770(1):79-86.
Unique glycerophospholipid signature in retinal stem cells correlates with enzymatic functions of diverse long-chain Acyl-CoA synthetases. Li J, Cui Z, Zhao S, Sidman RL.. Stem Cells. 2007;25(11):2864-2873.
Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry. Hicks AM, DeLong CJ, Thomas MJ, Samuel M, Cui Z.. Biochim Biophys Acta. 2006;1761(9):1022-1029.
Effector mechanisms of the anti-cancer immune responses of macrophages in SR/CR mice. Hicks AM, Willingham MC, Du W, Pang CS, Old LJ, Cui Z.. Cancer Immun. 2006;6(11):.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.